LifeWatch AG: AEVIS VICTORIA SA akzeptiert das überarbeitete Übernahmeangebot von
BioTelemetry

^
EQS Group-Ad-hoc: LifeWatch AG / Schlagwort(e): Übernahmeangebot
LifeWatch AG: AEVIS VICTORIA SA akzeptiert das überarbeitete
Übernahmeangebot von BioTelemetry

24.05.2017 / 11:26 CET/CEST
Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR

---------------------------------------------------------------------------

AEVIS VICTORIA SA akzeptiert das überarbeitete Übernahme-angebot von
BioTelemetry

ZUG/Schweiz, 24. Mai 2017 - AEVIS VICTORIA SA (SWX: AEVIS) gab heute
bekannt, dass sie das überarbeitete Übernahmeangebot von BioTelemetry für
LifeWatch AG annimmt.

Weitere Details wurden durch AEVIS VICTORIA SA publiziert (
http://www.aevis.com/websites/aevis/English/2111/ad-hoc-press-releases.html?newsID=1625815)

Für Rückfragen:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com

Zu LifeWatch AG
LifeWatch AG, mit Hauptsitz in Zug und Kotierung an der SIX Swiss Exchange
(LIFE) in der Schweiz, ist ein führender Anbieter von ferngesteuerten
diagnostischen "Digital Health" Dienstleistungen. Die Dienstleistungen von
LifeWatch liefern den Ärzten wichtige Informationen zur angemessenen
Behandlung ihrer Patienten mit dem Ziel, die Behandlung zu optimieren.
LifeWatch AG verfügt über operative Tochtergesellschaften in den USA, der
Schweiz, Israel und der Türkei und ist die Muttergesellschaft von LifeWatch
Services, Inc., LifeWatch Technologies Ltd. und LifeWatch Turkey Holding AG
(Joint Venture). LifeWatch Services, Inc. ist ein führender US-Anbieter für
Herzüberwachungsdienstleistungen. LifeWatch Technologies Ltd. in Israel ist
ein führender Hersteller von Digital-Health-Produkten. LifeWatch Salk
Hizmetlerine A.S. ist die operative Tochtergesellschaft der LifeWatch Turkey
Holding AG und Anbieter von Herzüberwachungsdienstleistungen in der Türkei.

Für weitere Informationen: siehe www.lifewatch.com.

E-Mail Alert: Um regelmässig die neusten Informationen zu LifeWatch zu
erhalten und Unterlagen anzufordern, registrieren Sie sich bitte unter
https://www.lifewatch.com/Investor-Relations/Alert-Service.html.

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release,
including statements regarding future results of operations and financial
position, the business strategy, and plans and objectives for future
operations, are forward-looking statements. The words "believe," "may,"
"will," "estimate," "continue," "anticipate," "intend," "expect" and similar
expressions are intended to identify forward-looking statements. LifeWatch
AG has based these forward-looking statements largely on current
expectations and projections about future events and financial trends that
it believes may affect the financial condition, results of operations,
business strategy, short-term and long-term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light of
these risks, uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press
release. LifeWatch AG does not undertake any obligation to update any
forward-looking statements contained in this press release as a result of
new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT
CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES
FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE
ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED,
SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM
REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.

Im Zweifelsfall gilt die englische Originalmeldung.

Zusatzmaterial zur Meldung:


Dokument: http://n.eqs.com/c/fncls.ssp?u=SNBYABWACP
Dokumenttitel: 20170524_Aevis acceptance

---------------------------------------------------------------------------

Ende der Ad-hoc-Mitteilung

---------------------------------------------------------------------------

   Sprache:          Deutsch
   Unternehmen:      LifeWatch AG
                     Baarerstrasse 139
                     6300 Zug
                     Schweiz
   Telefon:          +41 41 728 67 78
   Internet:         www.lifewatch.com
   ISIN:             CH0012815459
   Valorennummer:    811189
   Börsen:           Freiverkehr in Berlin, Stuttgart; Open Market in
                     Frankfurt; SIX Swiss Exchange



   Ende der Mitteilung    EQS Group News-Service
---------------------------------------------------------------------------

577035 24.05.2017 CET/CEST

°